Regarding the drug-related complications, 13 (1.1%) patients had leukopenia requiring GM-CSF, seven (0.6%) had anemia requiring blood transfusion, and five (0.4%) had thrombocytopenia. This evidence concerns the gene CSF2 and Thrombocytopenia.